Onderneming TOT BIOPHARM International Company Limited
Aandelen
1875
HK0000545266
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,68 HKD | +6,33% | +8,39% | -14,72% |
15/03 | TOT BIOPHARM International Company Limited rapporteert resultaten voor het volledige jaar dat eindigde op 31 december 2023 | CI |
2023 | Verlies TOT Biopharm kleiner in H1 | MT |
Vakgebied
Aantal werknemers: 552
Verkoop per activiteit
HKD in miljoen | 2021 | Gewicht | 2022 | Gewicht | Delta |
---|---|---|---|---|---|
Anti-tumor Drugs and Self-developed Biological Drugs
100,0
%
| 92 | 100,0 % | 514 | 100,0 % | +458,99% |
Verkoop per regio
HKD in miljoen | 2021 | Gewicht | 2022 | Gewicht | Delta |
---|---|---|---|---|---|
China
100,0
%
| 85 | 92,3 % | 514 | 100,0 % | +505,67% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jun Liu
CEO | Chief Executive Officer | 56 | 17-10-16 |
Ben Xiao
DFI | Director of Finance/CFO | 42 | 01-01-22 |
Ming Liu
CTO | Chief Tech/Sci/R&D Officer | 63 | 28-08-17 |
Director/Board Member | 65 | 05-07-10 | |
Shan Feng
LAW | General Counsel | 45 | 01-12-14 |
Yi Fan Chen
SEC | Corporate Secretary | 44 | 01-05-20 |
Wing Yat Lui
SEC | Corporate Secretary | 35 | 16-04-19 |
Chi-Yuen Wu
PRN | Corporate Officer/Principal | 52 | 01-01-16 |
Chun-Ming Lin
SAM | Sales & Marketing | 50 | 01-01-16 |
Xiaobao Chen
PRN | Corporate Officer/Principal | 42 | 20-06-16 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 65 | 05-07-10 | |
Hong Jen Chang
BRD | Director/Board Member | 68 | 12-03-19 |
Shan Fu
CHM | Chairman | 56 | 19-01-16 |
Jun Liu
CEO | Chief Executive Officer | 56 | 17-10-16 |
Lan Hu
BRD | Director/Board Member | 53 | 12-03-19 |
Wei Dong Liu
BRD | Director/Board Member | 56 | 12-08-23 |
De Qian Wang
BRD | Director/Board Member | 73 | 12-03-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 772 787 887 | 448 300 187 ( 58,01 %) | 0 | 58,01 % |
Bedrijfsgegevens
TOT BIOPHARM International Co. Ltd.
No.120 Changyang Street Suzhou Industrial Park
, Suzhou
+
http://www.totbiopharm.comSector
Verkoop per regio
Winst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-14,72% | 166 mln. | |
-2,31% | 103 mld. | |
+0,56% | 95,28 mld. | |
+1,69% | 22,15 mld. | |
-17,37% | 21,02 mld. | |
-9,30% | 18,15 mld. | |
-41,01% | 16,74 mld. | |
-14,85% | 16,05 mld. | |
+3,21% | 13,68 mld. | |
+33,54% | 12,17 mld. |
- Beurs
- Aandelen
- Koers 1875
- Onderneming TOT BIOPHARM International Company Limited